INTRODUCTION
============

Asthma is a treatable chronic disease of the airways that affects all age groups and has high prevalence, morbidity, and mortality around the world.[@B1] ^,^ [@B2] Many patients live with uncontrolled asthma, causing impaired quality of life and resulting in direct and indirect costs for societies, particularly in developing countries.[@B3] ^-^ [@B5] The prevalence of asthma (including severe asthma) is high in various countries, with a relevant impact on global public health care.[@B6] ^,^ [@B7] The populations in which the prevalence of asthma is highest (\> 20%) are observed in English-speaking countries and in Latin America.[@B8]

The prevalence of childhood asthma in Latin America varies widely (4-30% in children), but it is above 10% in virtually all countries.[@B9] ^-^ [@B12] The high burden of asthma in those countries is usually complicated by the limited access to health care and essential medications.[@B4] ^,^ [@B8] ^,^ [@B13] Brazil, a middle-income country of continental size, is one of the countries with the highest prevalences of asthma in children, with high rates of severe asthma.[@B6] ^,^ [@B7] ^,^ [@B14] We have recently shown that, in southern Brazil, 20% of school-age children have asthma, many of whom lacking control of the disease and presenting with high rates of physical inactivity, school absenteeism, and hospitalizations.[@B15] However, national data on the impact of asthma in developing countries are scarce. Data on mortality and number of hospitalizations regarding a particular disease are important to guide public health care policies. Large national databases are uncommon in developing countries. However, when available, such data become valuable information for improving health care policies for prevalent diseases.

Brazil has an official and longitudinal free-access database from the Brazilian Unified Health Care System, which records health indicators, such as mortality rates and number/costs of hospitalizations.[@B16] Thus, the aim of our study was to present longitudinal data regarding the impact of asthma in Brazil in recent years and to analyze geographic factors concerning the disease.

METHODS
=======

We conducted a descriptive study, based on asthma information collected from the *Departamento de Informática do Sistema Único de Saúde* (DATASUS, Information Technology Department of the Brazilian Unified Health Care System) database.[@B16] The population studied consisted of all cases of asthma -in accordance with the International Classification of Diseases, 10th revision (ICD-10; code J.45)-in which hospitalizations and deaths were reported between 2008 and 2013. For the geographic analysis, variables were corrected for population numbers in 2010, according to regions and states, using another database: the *Instituto Brasileiro de Geografia e Estatística* (IBGE, Brazilian Institute of Geography and Statistics) database, which provides data regarding the Brazilian population via periodic censuses.[@B17] Graphics were prepared using the GraphPad Prism statistical software program, version 6 (GraphPad Inc., San Diego, CA, USA). The DATASUS database is under public domain; hence, approval of our research ethics committee was not required.

Data from the DATASUS database were subdivided into three groups for analysis: Brazil, regions, and states. The following variables were analyzed: number of deaths, number of hospitalizations, length of hospital stay, and financial costs of hospitalization.

For the general analysis, our survey was carried out from 2008 to 2013, using the Health Information System tool. For the variables analyzed, we used the tables of Epidemiology and Morbidity in the "Hospital Morbidity" group, and then the "General, by hospital location" sub-item. In the filter options, the items "years", "contents of hospitalizations", "mean length of hospital stay", "total cost", "mean cost of hospitalization", and "deaths" were selected and correlated with "asthma" (ICD-10 code, J.45). Data regarding total deaths, aiming to cover all cases of asthma-related deaths and not only those related to hospitalizations, were collected from the Brazilian National Mortality Database, using the "Vital Statistics" item (Mortality Group, 1996 to 2014) and the "General Mortality" sub-item. In the filter options, we then selected, per year, the terms "deaths" and "asthma" (ICD-10, code J.45). The criteria for the analyses of regions and states followed the standards of the general analysis, with regions and states selected only regarding the year of 2010. The variables were corrected by the populations in 2010, in accordance with the IBGE census of that year.

The results concerning asthma-related mortality of hospitalized patients refer to the total number of asthma-related deaths of hospitalized patients, divided by the total number of hospitalizations due to asthma, and multiplied by 100. In relation to the regions and states, in order to calculate the numbers of asthma-related hospital admissions and asthma-related deaths of hospitalized patients per 100,000 population, both variables were divided by the total population of the respective location and multiplied by 100,000, using only the data from 2010. All asthma-related costs of hospitalizations in Brazilian reals (R\$) were converted to American dollars (USD), on the basis of the exchange rate on June 29, 2016 (USD 1.00 = R\$ 3,237).

RESULTS
=======

The total numbers of asthma-related total deaths and of hospitalizations decreased from 2008 to 2013, despite the high absolute numbers observed. In 2013, the last year analyzed, 2,047 people died from asthma in Brazil, meaning approximately 5 deaths/day and more than 120,000 hospitalizations per year. In six years, the absolute numbers of asthma-related deaths and hospitalizations decreased by 10% and 36%, respectively. However, the asthma-related mortality rate in hospitalized patients increased by approximately 25% during that period. The mean length of hospital stay due to asthma remained at approximately 3 days. These results are presented in [Figure 1](#f1){ref-type="fig"}.

Figure 1Overall asthma-related mortality, number of hospitalizations, inpatient mortality rate, and mean length of hospital stay in Brazil (2008-2013).

Geographically, we analyzed the numbers of asthma-related hospitalizations and deaths in hospitalized patients in 2010 by regions and representative states. Analyzing the different regions of Brazil, we found that the northern/northeastern and southeastern regions showed the highest rates of asthma-related hospitalizations and deaths of hospitalized patients, respectively. The mean number of asthma-related hospitalizations by region in 2010 was 110 hospitalizations/100~,~000 population, and the proportion of deaths among hospitalized patients was 0.46% ([Figure 2](#f2){ref-type="fig"}). The mean length of hospital stay was similar among the regions, ranging from 2.8 to 3.3 days. When we evaluated the states selected to represent the regions of Brazil ([Figure 3](#f3){ref-type="fig"}), we observed that the states of Pará (northern region) and Bahia (northeastern region) had the largest numbers of asthma-related hospitalizations/100,000 population. The states of São Paulo (southeastern region), Goiás (central-west region), and Rio Grande do Sul (southern region) revealed numbers of asthma-related deaths among hospitalized patients above the mean. We also observed that, in some regions or states, there was a discrepancy between the number of asthma-related hospitalizations/100~,~000 population and the mortality rate in hospitalized patients. [Figure 2](#f2){ref-type="fig"} shows that the northern and northeastern regions had numbers of asthma-related hospitalizations above the mean, whereas the mortality rates were below the mean. In contrast, the southeastern region had fewer asthma-related hospitalizations but more deaths among hospitalized patients than the overall mean. In addition, [Figure 3](#f3){ref-type="fig"} shows the same discrepancy in the states of Pará and Bahia (more asthma-related hospitalizations per capita and fewer deaths in hospitalized patients), which was the opposite in the state of São Paulo (fewer asthma-related hospitalizations per capita and more deaths in hospitalized patients).

Figure 2Number of asthma-related hospitalizations and inpatient mortality rates in the regions of Brazil (base year, 2010).

Figure 3Number of asthma-related hospitalizations and inpatient mortality rates in the Brazilian states selected for regional analysis (base year, 2010). RS: Rio Grande do Sul.

Finally, the asthma-related costs of hospital admissions in Brazil decreased during the period studied, despite the economic inflation ([Table 1](#t1){ref-type="table"}). However, the cost of hospitalizations to the public health care system reached almost USD 170 million. The mean cost of each asthma-related hospitalization was USD 160.00 (values indexed and calculated by the Brazilian public health care system). In addition, the mean cost of asthma-related hospitalizations was similar among the regions and the states of Brazil ([Table 2](#t2){ref-type="table"}).

Table 1Total number of asthma-related hospitalizations and their costs in Brazil (2008-2013).YearHospitalization, nCost, USDMean cost, USD2008205,27630,195,020.86147.092009203,64932,708,217.35160.612010193,01731,165,431.83161.462011175,95528,720,338.89163.232012146,55924,153,812.17164.812013129,72821,490,888.95165.66Total1,054,184168,433,710.05160.48[^1]

Table 2Total number of asthma-related hospitalizations and their costs by region and representative states in Brazil (2010).LocationPopulation, nHospitalization, nTotal cost, USDMean cost, USDRegionsNorth15,864,45421,6023,375,973.22156.28Northeast53,081,95088,09013,509,808.13153.36Southeast80,364,41040,9797,221,726.37176.23South27,386,89128,8274,910,306.62170.34Central-west14,058,09413,5192,147,617.49158.86Total190,755,799193,01731,165,431.83161,46StatesPará7,581,05115,6472,413,448.59154.24Bahia14,016,90635,5285,453,139.31153.49São Paulo41,262,19916,5942,940,473.82177.20Rio Grande do Sul10,693,92910,2651,734,000.03168.92Goiás6,003,7886,9351,109,985.82160.06Total79,557,87384,96913,651,047.57162.78[^2]

DISCUSSION
==========

Asthma, among other chronic respiratory diseases, represents an important global health problem, resulting in a negative social impact on various populations.[@B18] Unfortunately, for the governments of many countries, asthma is not a health care priority.[@B4] Brazil has a high prevalence of asthma and severe asthma, which is also observed in other countries in Latin America.[@B6] ^-^ [@B8] ^,^ [@B13] Nevertheless, there is a lack of official national data on the impact of asthma in Latin America. Our results show official longitudinal numbers of asthma-related deaths and hospital admissions in the largest country of Latin America, which might help to improve national asthma care, the quality of life of patients, and the control of costs of the disease.

Asthma-related mortality in Brazil is still high. Although we observed a small reduction (10%) in the total number of deaths from 2008 to 2013, approximately 5 patients die from asthma daily in Brazil. Childhood asthma-related mortality in Brazil also decreased from 1980 to 2000,[@B19] suggesting a national trend toward a slow and gradual improvement in asthma-related deaths in the country. In 2000, most asthma-related deaths occurred in hospitals, and household deaths were more common in elderly patients.[@B20] In addition, one previous analysis of asthma-related mortality in Brazil from 1998 to 2009 showed increased mortality in less developed regions in comparison with more developed regions.[@B21] In the USA, one of the most developed countries in the world, with a population of over 300 million inhabitants, 3,630 deaths due to asthma were reported in 2013 (approximately 9.9 deaths/day).[@B22] Considering the population in the USA and in Brazil in that particular year, the asthma-related mortality rates were similar in the general population in both countries, with approximately 1 death/10,000 population. Given that asthma is a treatable disease, deaths due to asthma, often prematurely, should be a very rare fatality in this context. Public authorities, regardless of the degree of development of the country, should be continuously pursuing a reduction in asthma-related mortality.

Hospital admissions due to respiratory diseases are a negative outcome in the quality of life of patients and in the public health care system. DATASUS showed that Brazil has more than 120,000 asthma-related hospitalizations per year. However, there was a reduction of 36% of asthma-related hospital admissions during the period analyzed. This is a positive finding for the public health care system from an epidemiological point of view, and it is difficult to explain it in the context of the analysis of the present study. One possible explanation could be the implementation of a national public health care policy by the Brazilian National Ministry of Health, implemented in 2009, which provided free and easily accessible asthma medications (beclomethasone and albuterol) in the whole territory of the country.[@B23] This public health care policy might have facilitated the access to control and rescue medications for asthma patients across the country. In the USA, hospitalizations due to asthma remained stable between 2001 and 2009, with high economic costs,[@B24] ^,^ [@B25] emphasizing the importance of a permanent review of asthma control programs by health care systems. In the present study, we showed that asthma-related mortality in hospitalized patients was around 0.5%, with a 25% increase during the study period. Hence, less than 1% of hospitalized patients die from asthma in Brazil. This finding suggests that the management of severe asthma in inpatients appears to be effective, indicating that it is imperative that comprehensive studies on the reasons why household asthma-related deaths are so high in Brazil be conducted. Another positive finding was the length of asthma-related hospital stay in Brazil. The mean length of hospital stay was 3 days, regardless of geographic factors, which is similar to that in developed countries, such as the United Kingdom.[@B26] We believe that little can be modified regarding the inpatient conventional therapies available against this severe clinical situation in order to reduce the number of hospital days.

When the regions of Brazil were analyzed, the northern\\northeastern regions (less affluent populations) and the southeastern region (the most affluent population) showed the highest rates of asthma-related hospitalizations and deaths of hospitalized patients, respectively. The states of Pará (northern region) and Bahia (northeastern region) had the largest numbers of asthma-related hospitalizations per 100,000 population. The states of São Paulo (southeastern region), Goiás (central-west region), and Rio Grande do Sul (southern region) had a rate of asthma-related deaths among hospitalized patients above the mean. This information is important for the Brazilian public health care authorities and requires more detailed analyses in order to improve the management of asthma patients and asthma-related costs. In this context, two Brazilian cities implemented distinct public health care programs for asthma (with the creation of referral centers, easy provision of medications, strict public health care protocols, and professional training) and were successful in achieving an important decrease in the number of asthma-related hospitalizations.[@B27] ^,^ [@B28] Moreover, in one of these cities (Salvador, in the state of Bahia), the implemented asthma control program showed that, when patients with severe asthma had their disease under control, there was a major decrease in the direct costs of asthma in the families (−89%) and an increase in the overall family income.[@B29] These local initiatives demonstrate the importance of implementing further effective asthma control programs in public health care systems.

An interesting finding was the discrepancy between the number of asthma-related hospital admissions and asthma-related mortality rates in hospitalized patients among the geographic regions. The northern\\northeastern regions showed asthma-related hospitalizations above the mean, which was the opposite regarding asthma-related mortality. In contrast, the southeastern region had fewer asthma-related hospitalizations but more asthma-related deaths in hospitalized patients than the overall mean. The same relationship was found in the representative states selected in the present study (i.e., Pará/Bahia and São Paulo). Once again, these data deserve an in-depth analysis by asthma control programs, considering the regional differences that are usually found particularly in large countries.

Inpatient care is the largest single component of direct asthma-related costs in public health.[@B30] The costs of asthma-related hospitalizations in our analysis followed the reduction in the number of hospital admissions observed, with no regional differences, especially considering the annual economic inflation of the period, which ranged from 4.4% to 6.5%.[@B31] Nevertheless, even with the reduction in asthma-related hospital admissions, the total cost of hospitalizations was still high. Almost USD 170 million were spent on asthma-related hospital admissions between 2008 and 2013. The mean cost of one hospitalization in Brazil is approximately USD 160.00. One may consider that the cost of one hospitalization in Brazil is low, but it is important to note that this is a value calculated by the government, which is paid to public health care providers (hospitals), and that, in fact, does not reflect the actual amount spent by the hospitals themselves. The issue of the cost of the disease stipulated by the Brazilian government (informed by DATASUS) and the "real" cost for the health care provider is another aspect that deserves public comprehensive public analysis and discussion, as well as an administrative-financial review. A recent systematic review of the costs of severe asthma in Brazil showed that the major direct expenses were related to hospitalizations and medications and that USD 733.00 were spent per patient per year, highlighting the elevated economic costs of asthma.[@B32]

Our study has limitations. This was a retrospective analysis of secondary data, which are subject to inadequate completion of medical records, including erroneous diagnosis of the disease. Underdiagnosis and underreporting are problems in any health care system, particularly in developing countries.[@B33] However, we have to consider that the data collected represent the official numbers of the Brazilian government, and limitations can be found in any country that implements this type of database. Nevertheless, we believe that DATASUS, with all its limitations, substantially helps to present relevant information on the impact of asthma in Brazil.

In conclusion, asthma-related mortality in Brazil is still very high if we take into account that asthma is a treatable disease. Despite the decrease in the number of asthma-related hospitalizations in recent years, the absolute numbers are still remarkable, resulting in relevant direct and indirect costs for the society. Finally, these results show that asthma should receive greater attention from the public health care authorities in Brazil and most other countries in Latin America.
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[^1]: USD: American dollars. Mean cost = total cost of hospitalizations/total number of hospitalizations.

[^2]: USD: American dollars. Mean cost = total cost of hospitalizations/total number of hospitalizations
